Trials / Completed
CompletedNCT03027232
Control of Leukocyte Function
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The protocol is to draw peripheral blood from healthy volunteers for in vitro studies. The aims of these in vitro studies are to determine the cellular and intracellular mechanisms by which hypertonic saline and ATP release regulate neutrophil and lymphocyte functions.
Detailed description
The proper regulation of leukocyte function is critical for immune defense and to prevent autoimmune diseases. Many aspects of immune cell regulation are unknown. A better understanding could lead to novel therapeutic approaches to improve immune function in patients suffering from various diseases. The investigators have found that hypertonic conditions regulate leukocyte functions through feedback mechanisms involving ATP release and purinergic receptors. The purpose of the proposed protocol is to obtain access to peripheral blood from healthy volunteers to study these complex regulatory mechanisms in more detail.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention (drugs) will be given. Purpose: collecting blood for in vitro studies | No drugs or interventions are given. Single purpose is to draw blood from healthy subjects to study immune cell biology in vitro. No records about subjects to be kept. |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2017-12-15
- Completion
- 2017-12-15
- First posted
- 2017-01-23
- Last updated
- 2018-04-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03027232. Inclusion in this directory is not an endorsement.